Cancer

Hepatocellular carcinoma (HCC) remains one of the most formidable challenges in oncology, notably within Egypt—the nation where it is the...

In recent years, the adolescent and young adult (AYA) cancer survivor population has gained increasing attention within oncological research, particularly...

Artificial intelligence is rapidly redefining the landscape of medical diagnostics, promising unprecedented capabilities in interpreting complex imaging data. A groundbreaking...

In a groundbreaking advancement for prostate cancer diagnosis, researchers have developed an innovative ultrasound molecular imaging technique aimed explicitly at...

Long non-coding RNAs (lncRNAs) are emerging as pivotal regulators within the tumor microenvironment (TME), reshaping our understanding of cancer biology...

In a groundbreaking effort to redefine treatment paradigms for oligometastatic prostate cancer (OMPC), researchers have launched a multicenter, randomized controlled...

In the evolving landscape of lung cancer treatment, the integration of immune checkpoint inhibitors (ICIs) with conventional chemotherapy regimens has...

In a significant advancement for the field of cancer immunology, Moffitt Cancer Center has unveiled a groundbreaking podcast titled The...

In the ever-evolving landscape of oncology, small cell carcinoma (SmCC) of the bladder remains one of the most enigmatic and...

In the evolving landscape of cancer treatment, immunotherapy has emerged as a revolutionary approach, particularly for patients with advanced non-small...